Atlas Trials

Effects of Rifaximin on Gut Microbiota and Emotion

Clinical trial NCT05587036 · RECRUITING

Trial details

NCT number
NCT05587036
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Healthy VolunteersStressFear
Start date
2023-02-02
Primary completion
2025-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.